{"id":"https://openalex.org/W3138917052","doi":"https://doi.org/10.3389/fphar.2021.586370","title":"Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation","display_name":"Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation","alternate_titles":[],"publication_year":2021,"publication_date":"2021-03-23","ids":{"openalex":"https://openalex.org/W3138917052","doi":"https://doi.org/10.3389/fphar.2021.586370","mag":"3138917052","pmid":"https://pubmed.ncbi.nlm.nih.gov/33867975","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8044929"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.586370","doi":"https://doi.org/10.3389/fphar.2021.586370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.586370","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.586370/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3138917052"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.586370/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074193099","display_name":"Woldesellassie M Mequanint Bezabhe","orcid":"https://orcid.org/0000-0002-3028-6949","observed_orcids":["https://orcid.org/0000-0002-3028-6949"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Woldesellassie Bezabhe","raw_affiliation_strings":["University of Tasmania Faculty of Health","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086021234","display_name":"Lre Bereznicki","orcid":"https://orcid.org/0000-0003-3974-3437","observed_orcids":["https://orcid.org/0000-0003-3974-3437"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Luke Bereznicki","raw_affiliation_strings":["University of Tasmania Faculty of Health","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075388292","display_name":"Jan C. Radford","orcid":"https://orcid.org/0000-0002-5751-0488","observed_orcids":["https://orcid.org/0000-0002-5751-0488"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jan Radford","raw_affiliation_strings":["University of Tasmania Faculty of Health","Launceston Clinical School, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS, Australia","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"Launceston Clinical School, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020979086","display_name":"Barbara C. Wimmer","orcid":"https://orcid.org/0000-0003-3166-7126","observed_orcids":["https://orcid.org/0000-0003-3166-7126"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Barbabra Wimmer","raw_affiliation_strings":["University of Tasmania Faculty of Health","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059914980","display_name":"Colin Michael Curtain","orcid":"https://orcid.org/0000-0001-5029-7541","observed_orcids":["https://orcid.org/0000-0001-5029-7541"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Colin Curtain","raw_affiliation_strings":["University of Tasmania Faculty of Health","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024137558","display_name":"Mohammed Saji Salahudeen","orcid":"https://orcid.org/0000-0001-9131-7465","observed_orcids":["https://orcid.org/0000-0001-9131-7465"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mohammed Salahudeen","raw_affiliation_strings":["University of Tasmania","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006038504","display_name":"Gregory Mark Peterson","orcid":"https://orcid.org/0000-0002-6764-3882","observed_orcids":["https://orcid.org/0000-0002-6764-3882"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Gregory Peterson","raw_affiliation_strings":["University of Tasmania Faculty of Health","School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tasmania Faculty of Health","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia","institution_ids":["https://openalex.org/I129801699"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074193099"],"corresponding_institution_ids":["https://openalex.org/I129801699"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":4.7287,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.96308371,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"12","issue":null,"first_page":"586370","last_page":"586370"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.9369999766349792},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/stroke-risk","display_name":"stroke risk","score":0.6389999985694885},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.5820000171661377},{"id":"https://openalex.org/keywords/general-practice","display_name":"general practice","score":0.6769999861717224},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8870000243186951},{"id":"https://openalex.org/keywords/appropriateness-of-prescribing","display_name":"appropriateness of prescribing","score":0.7570000290870667},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5839999914169312},{"id":"https://openalex.org/keywords/australia","display_name":"Australia","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9418588280677795},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8791609406471252},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.7556983232498169},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5964400172233582},{"id":"https://openalex.org/C2781318095","wikidata":"https://www.wikidata.org/wiki/Q33127638","display_name":"General practice","level":2,"score":0.5013267993927002},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4984016418457031},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4854205548763275},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.4457218050956726},{"id":"https://openalex.org/C2984752397","wikidata":"https://www.wikidata.org/wiki/Q3259956","display_name":"Primary care","level":2,"score":0.4300164580345154},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.35661494731903076},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3502366542816162},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.24045032262802124},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.09915831685066223},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0701475441455841},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fphar.2021.586370","doi":"https://doi.org/10.3389/fphar.2021.586370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.586370","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.586370/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"doi:10.22541/au.159015535.57758232","doi":"https://doi.org/10.22541/au.159015535.57758232","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.159015535.57758232","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.159015535.57758232","source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:33867975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33867975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8044929","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8044929/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:6ac888411ead46278adc70593ffba792","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6ac888411ead46278adc70593ffba792","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/22997381","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Ten-Year_trends_in_the_use_of_oral_anticoagulants_in_Australian_general_practice_patients_with_atrial_fibrillation/22997381","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.586370","doi":"https://doi.org/10.3389/fphar.2021.586370","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.586370","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.586370/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3138917052.pdf","grobid_xml":"https://content.openalex.org/works/W3138917052.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2005561452","https://openalex.org/W2023143117","https://openalex.org/W2023448396","https://openalex.org/W2097854437","https://openalex.org/W2136489990","https://openalex.org/W2162508946","https://openalex.org/W2164861810","https://openalex.org/W2168008722","https://openalex.org/W2579323441","https://openalex.org/W2587696432","https://openalex.org/W2604738434","https://openalex.org/W2735987663","https://openalex.org/W2792707559","https://openalex.org/W2792857103","https://openalex.org/W2794505502","https://openalex.org/W2799311941","https://openalex.org/W2879889508","https://openalex.org/W2905043725","https://openalex.org/W2959873153","https://openalex.org/W2993794072","https://openalex.org/W4294214983","https://openalex.org/W6929062034"],"related_works":["https://openalex.org/W3048941456","https://openalex.org/W2625703504","https://openalex.org/W2735987663","https://openalex.org/W4229039726","https://openalex.org/W3120380687","https://openalex.org/W3109555377","https://openalex.org/W2745038123","https://openalex.org/W2761548614","https://openalex.org/W4385383594","https://openalex.org/W4406783082"],"abstract_inverted_index":{"Objective:":[0],"Appropriate":[1],"use":[2],"of":[3,10,23,51,57,70,96,124,170,208,226],"oral":[4,202],"anticoagulants":[5,203],"(OACs)":[6],"reduces":[7],"the":[8,21,30,94,168,200,224,244,255,262],"risk":[9,83,99,177,231,270],"stroke":[11,82,98,176,230,269],"in":[12,25,29,114,131,135,150,157,216,243,254,267,281],"patients":[13,52,71,100,125,171,232,271],"with":[14,27,53,72,126,172,199,272],"atrial":[15],"fibrillation":[16],"(AF).":[17],"The":[18,68,90,109,121,137],"study":[19],"characterized":[20],"prescribing":[22,116,218,266,283],"OACs":[24],"people":[26],"AF":[28,58,73,127,173,273],"Australian":[31],"primary":[32,91],"care":[33],"setting":[34],"over":[35,106,206],"10":[36,47,263],"years.":[37],"Design:":[38],"Retrospective":[39],"population":[40],"study.":[41],"Setting":[42],"and":[43,61,87,174,249],"Participants:":[44],"We":[45],"performed":[46],"sequential":[48],"cross-sectional":[49],"analyses":[50],"a":[54,107],"recorded":[55],"diagnosis":[56],"between":[59,219,284],"2009":[60,132,151],"2018":[62,158],"using":[63],"national":[64],"general":[65,118,220,285],"practice":[66,246,257],"data.":[67],"proportion":[69,95,138,169,225],"who":[74,101,139,178,233],"were":[75,102,140,179,234],"prescribed":[76,103,141,180,235],"an":[77,104,142,181,236],"OAC":[78,105,115,143,182,217,237,265,282],"based":[79],"on":[80],"their":[81],"was":[84,93,112,213,238,278],"examined.":[85],"Primary":[86],"secondary":[88,110],"outcomes:":[89],"outcome":[92,111],"high":[97,175,229,268],"decade.":[108],"variation":[113,215,280],"among":[117],"practices.":[119,221,286],"Results:":[120],"sample":[122],"size":[123],"ranged":[128],"from":[129,145,184],"9,874":[130],"to":[133,152,189,228],"41,751":[134],"2018.":[136,211],"increased":[144,274],"39.5%":[146],"(95%":[147,154,186,191,240,251],"CI":[148,155,187,192,241,252],"38.6\u201340.5%)":[149],"52.0%":[153],"51.5\u201352.4%)":[156],"(":[159],"p":[160,194],"for":[161,195,205],"trend":[162,196],"<":[163,197],"0.001).":[164],"During":[165],"this":[166],"time,":[167],"rose":[183],"41.7%":[185],"40.7\u201342.8%)":[188],"55.2%":[190],"54.7\u201355.8%;":[193],"0.001)":[198],"direct-acting":[201],"accounting":[204],"three-quarters":[207],"usage":[209],"by":[210,275],"There":[212,277],"substantial":[214],"In":[222],"2018,":[223],"moderate":[227],"38.6%":[239],"37.2\u201340.1%)":[242],"lowest":[245],"site":[247,258],"quintiles":[248],"65.6%":[250],"64.5\u201366.7%)":[253],"highest":[256],"quintiles.":[259],"Conclusions:":[260],"Over":[261],"years,":[264],"one-third.":[276],"considerable":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3138917052","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2021-03-29T00:00:00"}
